Cable Hill Partners, LLC Red Hill Biopharma Ltd. Transaction History

Cable Hill Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 20, 2018	SELL	$4.96 - $6.84 $4 - $6	-1 Closed	0 $0
Q4 2017 Feb 22, 2018	SELL	$4.58 - $10.81 $4,575 - $10,799	-999 Reduced 99.9%	1 $0
Q3 2017 Oct 27, 2017	BUY	$8.25 - $10.81 $8,250 - $10,810	1,000	1,000 $11,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.